KIDNEY TRANSPLANT OUTCOMES ARE RELATED TO MYCOPHENOLIC ACID EXPOSURE AT 5 WEEKS AND 3 MONTHS POST TRANSPLANT

P KOTAGIRI1, R MASTERSON1, P HUGHES1, K BARRACLOUGH1
1Royal Melbourne Hospital, Parkville, Australia

Aim: To examine for associations between mycophenolic acid (MPA) exposure at week 5 (w5) and month 3 (m3) post-kidney transplant and clinical outcomes in recipients treated with mycophenolate mofetil (MMF), tacrolimus and prednisolone.
Background: RCT data supports a MPA AUC0-12 target of 30-60mg·h/L early post-kidney transplant. A single study has suggested AUC0-12 should remain >30mg·h/L for the entire first year but the majority in this trial received cyclosporine and had corticosteroids withdrawn.
Methods: This retrospective study involved individuals transplanted between 2015-2017 who had MPA AUC0-12 estimated at w5 and m3. Outcomes examined included rejection, neutropenia, anaemia, diarrhoea, BK and CMV viremia and infections requiring hospitalisation.
Results: 216 individuals were studied. Rejection after the first month was seen in 18% and was more frequent with a w5 AUC0-12 <20mg·h/L (80% vs. 20%; p=0.002). Using multivariate logistic regression, a w5 AUC0-12 <20mg·h/L was independently predictive of subsequent rejection AOR 25.2 (95%CI 2.5,252.3;p=0.006). Neutropenia occurred in 26% and was more frequent with a w5 MPA AUC0-12 >40mg·h/L (32% vs. 19%;p=0.05), and was even more pronounced when AUC0-12 cut-off values of 50mg·h/L and 60mg·h/L were considered (48% vs. 16%,p<0.001; and 56% vs. 19%,p<0.001). Similarly, neutropenia was more frequent with a m3 AUC0-12 >40mg·h/L (45% vs. 25%;p=0.02), with the proportion affected again increasing with higher AUC0-12 cut-off values No associations were observed between m3 AUC0-12 and rejection or w5 or m3 AUC0-12 and any other toxicities examined.
Conclusions: These data suggest 20mg·h/L might be an appropriate minimum target at w5 in individuals receiving MMF, tacrolimus and steroids. However, larger studies are needed. The increased neutropenia seen with increasing MPA AUC0-12 highlights the importance of balancing risks of under and over-exposure.


Biography:
Renal Registrar at the Royal Melbourne Hospital

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

© 2015 - 2016 Conference Design Pty Ltd